Japan
Amgen to Serve Japanese Healthcare Market with Complete Ownership of 7 Year Joint Venture
2020-04-01
Daiichi Sankyo Seeks Yescarta Approval in Japan for Relapsed or Refractory B-cell Lymphoma
2020-04-01
Weekly Cover: Eisai to Launch “NouKNOWTM” in Japan for Regular Self-assessment of Brain Health
2020-03-26
Japan Approves World’s First Therapy for Metastatic Non–Small Cell Lung Cancer with METex14
2020-03-26
Japan Grants Orphan Drug Designation to Lynparza for Germline BRCA-mutated Pancreatic Cancer
2020-03-25
Highlights on the 21st INTERPHEX Week Japan 2019: The Future of Pharmaceutical – Robotics, Regenerative Medicine, and Cross-industry Collaborations
2019-07-16
Novo Nordisk Pharma Ltd. Partners with Health2Sync in Japan, Bringing Digital Diabetes Management to Healthcare Providers and Patients
2019-03-05
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115